Zhang X - Search Results

1

Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.

Fu X, Rivera A, Tao L, Zhang X. Fu X, et al. Among authors: zhang x. Mol Ther. 2012 Oct;20(10):1871-81. doi: 10.1038/mt.2012.113. Epub 2012 Jun 12. Mol Ther. 2012. PMID: 22692498 Free PMC article.

2

Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype.

Fu X, Zhang X. Fu X, et al. Among authors: zhang x. Cancer Res. 2002 Apr 15;62(8):2306-12. Cancer Res. 2002. PMID: 11956088

3

High-frequency intermolecular homologous recombination during herpes simplex virus-mediated plasmid DNA replication.

Fu X, Wang H, Zhang X. Fu X, et al. Among authors: zhang x. J Virol. 2002 Jun;76(12):5866-74. doi: 10.1128/jvi.76.12.5866-5874.2002. J Virol. 2002. PMID: 12021319 Free PMC article.

4

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.

Fu X, Tao L, Jin A, Vile R, Brenner MK, Zhang X. Fu X, et al. Among authors: zhang x. Mol Ther. 2003 Jun;7(6):748-54. doi: 10.1016/s1525-0016(03)00092-3. Mol Ther. 2003. PMID: 12788648 Free article.

5

Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms.

Nakamori M, Fu X, Meng F, Jin A, Tao L, Bast RC Jr, Zhang X. Nakamori M, et al. Among authors: zhang x. Clin Cancer Res. 2003 Jul;9(7):2727-33. Clin Cancer Res. 2003. PMID: 12855653

Incorporation of membrane fusion capability into an oncolytic HSV, either by screening for a syncytial HSV mutant after random mutagenesis or by inserting a hyperfusogenic glycoprotein from gibbon ape leukemia virus into the viral genome, can significantly enhance the antitumor e …

Incorporation of membrane fusion capability into an oncolytic HSV, either by screening for a syncytial HSV mutant after random mutagenesis o …

6

Destruction of nonimmunogenic mammary tumor cells by a fusogenic oncolytic herpes simplex virus induces potent antitumor immunity.

Nakamori M, Fu X, Rousseau R, Chen SY, Zhang X. Nakamori M, et al. Among authors: zhang x. Mol Ther. 2004 May;9(5):658-65. doi: 10.1016/j.ymthe.2004.02.019. Mol Ther. 2004. PMID: 15120326 Free article.

7

A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.

Fu X, Tao L, Cai R, Prigge J, Zhang X. Fu X, et al. Among authors: zhang x. Mol Ther. 2006 May;13(5):882-90. doi: 10.1016/j.ymthe.2006.02.007. Epub 2006 Mar 29. Mol Ther. 2006. PMID: 16569513 Free article.

8

Effective treatment of pancreatic cancer xenografts with a conditionally replicating virus derived from type 2 herpes simplex virus.

Fu X, Tao L, Li M, Fisher WE, Zhang X. Fu X, et al. Among authors: zhang x. Clin Cancer Res. 2006 May 15;12(10):3152-7. doi: 10.1158/1078-0432.CCR-06-0045. Clin Cancer Res. 2006. PMID: 16707615

9

Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.

Li H, Dutuor A, Tao L, Fu X, Zhang X. Li H, et al. Among authors: zhang x. Clin Cancer Res. 2007 Jan 1;13(1):316-22. doi: 10.1158/1078-0432.CCR-06-1625. Clin Cancer Res. 2007. PMID: 17200370

10

Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model.

Li H, Dutuor A, Fu X, Zhang X. Li H, et al. Among authors: zhang x. J Gene Med. 2007 Mar;9(3):161-9. doi: 10.1002/jgm.1005. J Gene Med. 2007. PMID: 17266169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167,966 results

Search Page